Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
company, TreeFrog Therapeutics, to optimize the production of VRTX's type 1 diabetes (T1D) cell therapies. The agreement will grant the pharmaceutical company an exclusive license to TreeFrog's proprietary cell manufacturing technology, C-Stem, which will be leveraged by VRTX to enhance its ability to generate large amounts of fully differentiated insulin-producing pancreatic islet cells for its portfolio of T1D cell therapies. TreeFrog's C-Stem technology imitates the natural microenvironment of cells that facilitates those cells to grow exponentially in a three-dimensional setting. Year to date, shares of Vertex have lost 1.7% compared with the industry's 11.1% decline. Image Source: Zacks Investment Research Per the terms of the agreement, VRTX is liable to make an upfront payment of $25 million to TreeFrog in consideration of the C-Stem license grant while making an equity investment in the partner company. Additionally, Vertex is also liable to make milestone payments t
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]Yahoo! Finance
- American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]Yahoo! Finance
- 2 Top Growth Stocks to Buy Right Now and Hold Forever [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 2/5/24 - Beat
VRTX
Sec Filings
- 5/2/24 - Form 144
- 4/17/24 - Form 4
- 4/16/24 - Form PX14A6G
- VRTX's page on the SEC website